Back to top
more

Neogen (NEOG)

(Real Time Quote from BATS)

$16.41 USD

16.41
182,568

+0.08 (0.49%)

Updated Jul 22, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NEOG

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Neogen Corporation falls in the month of May.

All items in Millions except Per Share data.

5/31/2024 5/31/2023 5/31/2022 5/31/2021 5/31/2020
Assets          
Cash & Equivalents -99,999 246 381 381 344
Receivables NA 153 100 92 85
Notes Receivable NA 0 0 0 0
Inventories NA 134 122 101 95
Other Current Assets NA 53 24 18 14
Total Current Assets NA 586 627 591 537
Net Property & Equipment NA 199 111 100 79
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 3,743 250 224 177
Deposits & Other Assets NA 15 2 2 2
Total Assets NA 4,554 993 920 797
Liabilities & Shareholders Equity 5/31/2024 5/31/2023 5/31/2022 5/31/2021 5/31/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 77 35 24 26
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 62 41 28 21
Income Taxes Payable NA 7 2 2 1
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 145 78 54 48
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 353 17 22 18
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 885 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 36 11 4 5
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,420 106 80 72
Shareholders Equity 5/31/2024 5/31/2023 5/31/2022 5/31/2021 5/31/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 35 17 17 8
Capital Surplus NA 2,568 310 295 258
Retained Earnings NA 565 588 540 479
Other Equity NA -33 -28 -11 -20
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 3,134 887 840 725
Total Liabilities & Shareholder's Equity NA 4,554 993 920 797
Total Common Equity 0 3,134 887 840 725
Shares Outstanding 216.60 216.20 107.80 107.00 105.40
Book Value Per Share 0.00 14.50 8.23 7.85 6.88

Fiscal Year End for Neogen Corporation falls in the month of May.

All items in Millions except Per Share data.

5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Assets          
Cash & Equivalents -99,999 168 230 239 246
Receivables NA 174 151 138 153
Notes Receivable NA 0 0 0 0
Inventories NA 182 161 141 134
Other Current Assets NA 78 83 66 53
Total Current Assets NA 602 624 584 586
Net Property & Equipment NA 272 244 221 199
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 3,676 3,703 3,726 3,743
Deposits & Other Assets NA 16 16 16 15
Total Assets NA 4,582 4,602 4,561 4,554
Liabilities & Shareholders Equity 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 90 112 90 77
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 3 3 3 0
Accrued Expenses NA 54 52 36 62
Income Taxes Payable NA 12 10 5 7
Other Current Liabilities NA 0 0 4 0
Total Current Liabilities NA 158 177 138 145
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 354 355 355 353
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 888 887 886 885
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 36 36 36
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,436 1,455 1,415 1,420
Shareholders Equity 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 35 35 35 35
Capital Surplus NA 2,580 2,575 2,572 2,568
Retained Earnings NA 561 563 567 565
Other Equity NA -29 -25 -27 -33
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 3,146 3,148 3,146 3,134
Total Liabilities & Shareholder's Equity NA 4,582 4,602 4,561 4,554
Total Common Equity 0 3,146 3,148 3,146 3,134
Shares Outstanding 216.60 216.60 216.50 216.30 216.20
Book Value Per Share 0.00 14.53 14.54 14.55 14.50